Panafcort 5 mg TABLETS
PDF Leaflet Revision Date: 08 November 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Severe or acute rheumatic, dermatological and allergic conditions.
Dosage (summary)
2 to 20 tablets daily in divided doses, taken with or after food.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Use with caution; may cause fetal malformations and hypoadrenalism in infants.
Key Drug Interactions
- CYP3A inhibitors
- Anticoagulants
- Antidiabetic medicines
Contraindications
- Hypersensitivity to prednisone
- Peptic ulcer
- Osteoporosis
- Psychosis
- Acute infections
Common side effects
- Increased susceptibility to infections
- Hypertension
- Hyperglycemia
- Mood changes
- Osteoporosis
Counselling Points
- Take with food
- Monitor for signs of infection
- Do not stop abruptly
- Report mood changes
Serious warnings
- Adrenal insufficiency on withdrawal
- Increased risk of infections
- Psychiatric effects
Important Disclaimer
The Panafcort 5 mg TABLETS professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
